Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Leukemia|November 25, 2023
TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclaxAnudishi Tyagi, Appalaraju Jaggupilli, Stanley Ly, et al.
Frontiers in Immunology|October 7, 2022
Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopeniaBijender Kumar, Vahid Afshar-Kharghan, Mayela Mendt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2019
ImmunoPET, [<sup>64</sup>Cu]Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft ModelSargur Madabushi Srideshikan, Jamison Brooks, Darren Zuro, et al.
Virchows Archiv : an International Journal of Pathology|February 23, 2024
Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agentsMario L Marques-Piubelli, Bijender Kumar, Rafet Basar, et al.
Journal of Cellular Physiology|February 17, 2019
8-chloro-adenosine activity in FLT3-ITD acute myeloid leukemiaRalf Buettner, Le Xuan Truong Nguyen, Bijender Kumar, et al.
Cell Reports|January 4, 2025
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cellsLuciana Melo Garcia, Achintyan Gangadharan, Pinaki Banerjee, et al.
Nature Medicine|March 6, 2018
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemiaBin Zhang, Le Xuan Truong Nguyen, Ling Li, et al.
Cancer Cell|August 22, 2025
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potencyAlexander Biederstädt, Rafet Basar, Jeong-Min Park, et al.
Frontiers in Immunology|May 21, 2021
Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHDMayela Mendt, May Daher, Rafet Basar, et al.
Nature Communications|April 11, 2025
Natural killer cells' functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Bijender Kumar, et al.
Pageof 8